Suppression of injury-induced epithelial-mesenchymal transition in a mouse lens epithelium lacking tenascin-C

Molecular Vision

Volumn 16, Issue , 2010, Pages 1194-1205

  Tanaka, Sai Ichi ^a   Sumioka, Takayoshi ^a   Fujita, Norihito ^a   Kitano, Ai ^a   Okada, Yuka ^a   Yamanaka, Osamu ^a   Flanders, Kathleen C ^b   Miyajima, Masayasu ^a   Saika, Shizuya ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 9; PROTEIN KINASE C; RHO KINASE; SMAD2 PROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL ELONGATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EYE INJURY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LENS CAPSULE; LENS EPITHELIUM; LENS INJURY; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WILD TYPE; WOUND HEALING;

ANIMALS; CALMODULIN-BINDING PROTEINS; EPITHELIUM; FIBRONECTINS; IMMUNOHISTOCHEMISTRY; LENS, CRYSTALLINE; MESODERM; MICE; MICE, INBRED C57BL; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD2 PROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77955645467     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995; 26:678-90.
2. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC. Smad3 is key to TGF-β-mediated epithelialto-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006; 17:19-27.
3. Saika S, Kawashima Y, Miyamoto T, Tanaka SI, Ohmi S, Minamide A, Yamanaka O, Ohnishi Y, Ooshima A, Yamanaka A. Immunolocalization of prolyl 4-hydroxylase subunits, α-smooth muscle actin, and extracellular matrix components in human lens capsules with lens implants. Exp Eye Res 1998; 66:283-94.
4. Saika S, Okada Y, Miyamoto T, Ohnishi Y, Ooshima A, McAvoy JW. Smad translocation and growth suppression in lens epithelial cells by endogenous TGFβ2 during wound repair. Exp Eye Res 2001; 72:679-86.
5. Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol 2000; 84:332-6.
6. Wormstone IM. Posterior capsular opacification: a cell biological perspective. Exp Eye Res 2002; 74:337-47.
7. Saika S. Relationship between posterior capsule opacification and intraocular lens biocompatibility. Prog Retin Eye Res 2004; 23:283-305.
8. Serini G, Bochaton-Piallat M-L, Ropraz P, Geinoz A, Borsi A, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J Cell Biol 1998; 142:873-81.
9. Serini G, Gabbiani G. Mechanism of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999; 250:273-83.
10. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3:349-63.
11. Saika S, Miyamoto T, Tanaka T, Ishida I, Ohnishi Y, Ooshima A. Latent TGFβ binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells. Br J Ophthalmol 2001; 85:1362-6.
12. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-β induced transdifferenttiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127:2021-36.
13. Srinivasan Y, Lovicu FJ, Overbeek PA. Lens specific expression of transforming growth factor β1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest 1998; 101:625-34.
14. Lee EH, Joo C-K. Role of transforming growth factor-β in transdifferentiation and fibrosis of lens epithelial cells. Invest Ophthalmol Vis Sci 1999; 40:2025-32.
15. Oft M, Akhurst RJ, Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 2002; 4:487-94.
16. Wormstone IM, Tamiya S, Andersone I, Duncan G. TGF-β2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 2002; 43:2301-8.
17. Saika S, Kono-Saika S, Ohnishi Y, Sato M, Muragaki Y, Ooshima A, Flanders KC, Yoo J, Anzano M, Liu CY, Kao WW, Roberts AB. Smad3 signaling is required for epithelialmesenchymal transition of lens epithelium after injury. Am J Pathol 2004; 164:651-63.
18. Saika S. TGFβ pathobiology in the eye. Lab Invest 2006; 86:106-15.
19. Hay ED. Extracellular matrix alters epithelial differentiation. Curr Opin Cell Biol 1989; 14:455-7.
20. Zuk A, Hay ED. Expression of β1 integrins changes during transformation of avian lens epithelium to mesenchyme in collagen gels. Dev Dyn 1994; 201:378-93.
21. Saika S, Miyamoto T, Tanaka S, Tanaka T, Ishida I, Ohnishi Y, Ooshima A, Ishiwata T, Asano G, Chikama T, Shirai A, Liu CY, Kao CW, Kao WW. Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 2003; 44:2094-102.
22. Zeisberg M, Bonner G, Maeshima Y, Colorad P, Muller GA, Strutz F, Kalluri R. Collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 2001; 159:1313-21.
23. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107:1055-61.
24. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006; 16:79-87.
25. Saika S, Miyamoto T, Ishida I, Ohnishi Y, Ooshima A. Osteopontin: a component of matrix in capsular opacification and subcapsular cataract. Invest Ophthalmol Vis Sci 2003; 44:1622-8.
26. Saika S, Shirai K, Yamanaka O, Miyazaki K, Okada Y, Kitano A, Flanders KC, Kon S, Uede T, Kao WW, Rittling SR, Denhardt DT, Ohnishi Y. Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium. Lab Invest 2007; 87:130-8.
27. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, Chapman HA. Epithelial cell alpha3beta1 integrin links betacatenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119:213-4.
28. Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis 2008; 29:2243-51.
29. Giehl K, Menke A. Microenvironmental regulation of Ecadherin-mediated adherens junctions. Front Biosci 2008; 13:3975-85.
30. Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol 2008; 38:95-104.
31. Chiquet-Ehrismann R. Tenascins. Int J Biochem Cell Biol 2004; 36:986-90.
32. Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 2008; 1793:888-92.
33. de Iongh RU, Wederell E, Lovicu FJ, McAvoy JW. Transforming growth factor-beta-induced epithelialmesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 2005; 179:43-55.
34. Orend G. Potential oncogenic action of tenascin-C in tumorigenesis. Int J Biochem Cell Biol 2005; 37:1066-83.
35. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett 2006; 244:143-63.
36. El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H, Sakakura T, Imanaka-Yoshida K. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol 2007; 211:86-94.
37. Imanaka-Yoshida K, Matsumoto K, Hara M, Sakakura T, Yoshida T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 2003; 71:291-8.
38. Liu PY, Liao JK. A method for measuring Rho kinase activity in tissues and cells. Methods Enzymol 2008; 439:181-9.
39. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-beta in human aqueous humor. Curr Eye Res 1990; 9:963-9.
40. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991; 32:2201-11.
41. Saika S, Liu CY, Azhar M, Sanford LP, Doetschman T, Gendron RL, Kao CW, Kao WW. TGFβ2 in corneal morphogenesis during mouse embryonic development. Dev Biol 2001; 240:419-32.
42. Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 2006; 18:276-84.
43. Cho HJ, Yoo J. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 2007; 31:1225-30.
44. Berndt JD, Clay MR, Langenberg T, Halloran MC. Rho-kinase and myosin II affect dynamic neural crest cell behaviors during epithelial to mesenchymal transition in vivo. Dev Biol 2008; 324:236-44.
45. Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci 1999; 40:1071-80.
46. Saika S, Ikeda K, Yamanaka O, Sato M, Muragaki Y, Ohnishi Y, Ooshima A, Nakajima Y, Namikawa K, Kiyama H, Flanders KC, Roberts AB. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest 2004; 84:1259-70.
47. Saika S, Ikeda K, Yamanaka O, Flanders KC, Ohnishi Y, Nakajima Y, Muragaki Y, Ooshima A. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 2006; 290:C282-9.